If you are using a Mozilla® Firefox® browser, Firefox has ended support for Java in March 2017. CareLink® Personal software uses Java plugins to upload data from Medtronic supported medical devices, such as the insulin pumps. Please click here for more information, or contact Customer Support if you have questions.



940M13758-016 20170306

©2017 Medtronic MiniMed, Inc. All rights reserved.

Select Region
Home
Top 10
Important Product Safety InformationAlert: Product and Safety Notice

About Us

Transforming diabetes care together, for greater freedom and better health


For more than 30 years, Medtronic has been helping people with diabetes.


Medtronic is working with the global community to change the way people manage diabetes. Together, we will transform diabetes care by expanding access, integrating care and improving outcomes, so people with diabetes can enjoy greater freedom and better health.


Under the leadership of Hooman Hakami, Executive Vice President and President of the Diabetes Group, Medtronic Diabetes operates three global business units to serve customers worldwide.


  • The Intensive Insulin Management Business Unit: This business unit serves the needs of those with type 1 diabetes and those who use intensive insulin regimens with type 2 diabetes. This business unit is our history and our heritage, and where we have offered a comprehensive approach to improve outcomes and care. We remain committed to innovation so that we can develop an artificial pancreas and close the loop.
  • The Non-Intensive Diabetes Therapies Business Unit: This business unit focuses on addressing the needs of patients with type 2 diabetes who do not use intensive insulin regimens and provides solutions along the diabetes care continuum. This team, working together with our partners, people with diabetes, providers, and payers, is focusing on developing products and solutions to improve clinical outcomes and reduce the burden of managing type 2 diabetes.
  • The Diabetes Service and Solutions Business Unit: This business unit optimizes clinical outcomes and enhances the customer experience with our therapies. We are focused on innovation in consumables, such as infusion sets and accessories, and in transforming how data is collected, analyzed and presented through our CareLink system. This team addresses broader needs, including patient education, efficiency in care delivery and financial services, to broaden access and enhance the satisfaction of all of our patients.


The Diabetes Group at Medtronic is part of Medtronic plc, the global leader in medical technology. We are proud of our long history of innovation and the Medtronic Mission, which continues to unite all of us worldwide in a higher purpose: to alleviate pain, restore health, and extend lives.

 

Hooman Hakami - Executive Vice President and President, Diabetes
Hooman Hakami

Executive Vice President and President, Diabetes


Hooman Hakami was named Executive Vice President and Group President of Medtronic Diabetes in June of 2014. Hooman provides overall strategic direction and operational management of the Group’s three global business units.


Hooman came to Medtronic after more than 20 years at General Electric. He was President and CEO of Detection & Guidance Solutions at GE Healthcare from April 2012 until May 2014. In that role he led that company’s business specializing in x-ray based technology solutions. Previously he served as President and CEO of the Interventional Systems business based in France, and the Global Clinical Systems Services for GE Healthcare.


Hooman received his Bachelor in Business Administration degree in operations management from the University of Massachusetts, where he graduated cum laude in 1991. Away from work he enjoys travel, sports, and spending time with his family.